Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Jul;5(7):e422-e425.
doi: 10.1016/S2665-9913(23)00100-5. Epub 2023 Jun 1.

The role of skin ultrasound in systemic sclerosis: looking below the surface to understand disease evolution

Affiliations
Review

The role of skin ultrasound in systemic sclerosis: looking below the surface to understand disease evolution

Gemma Lepri et al. Lancet Rheumatol. 2023 Jul.

Abstract

Skin ultrasound has shown promising results in the evaluation of skin involvement in patients with systemic sclerosis, as substantiated by a recent systematic literature review from the World Scleroderma Foundation Skin Ultrasound Working Group. In this Viewpoint, we will discuss the role of ultrasound in evaluating skin involvement in patients with systemic sclerosis, particularly the possibility of using this technique to detect an early subclinical skin involvement from the very early phase, suggesting its possible use in both diagnosis and disease follow-up. To detect subclinical skin involvement, it is essential to understand the difference between the skin of patients with systemic sclerosis and that of healthy controls, including defining exactly which structures are affected by the disease and which are spared. The potential of this non-invasive technique might suggest its future role in both clinical practice and clinical trials, possibly replacing invasive and painful procedures such as skin biopsies and promoting patient retention in clinical trials.

PubMed Disclaimer

Conflict of interest statement

Declaration of interests MH reports speaking fees from Actelion pharmaceuticals, Eli Lilly, Janssen, and Pfizer, outside of the submitted work; reports research funding from Janssen; and is a member of a data and safety monitoring board for Certa Therapeutics. YA reports grants from Alpine ImmunoSciences; consulting fees from Horizon, AstraZeneca, Boehringer Ingelheim, Janssen, Prometheus, Medsenic, Galderma, and AbbVie. CPD reports consulting fees from Arxx Therapeutics, Roche, Janssen, GlaxoSmithKline, Bayer, Sanofi, Galapagos, Boehringer Ingelheim, CSL Behring, AstraZeneca, and Acceleron. FDG reports consulting fees and research support from AbbVie, AstraZeneca, Boehringer Ingelheim, Chemomab, Janssen, and MitsubishiTanabe. DK reports grants from Bristol Myers Squibb, Horizon Therapeutics, and Pfizer; consulting fees from AstraZeneca, Boehinger Ingelheim, Bristol Myers Squibb, Chemomab, CSL Behring, Horizon Therapeutics, Janssen, Prometheus, Sanofi, Talaris, and Bauch Health. MMC reports participation on a data safety monitoring board or advisory board for Biogen, Gesynta, Chemomab, and Galapagos. All other authors report no competing interests.

LinkOut - more resources